Wednesday, 15 August 2018 - 12:13
  • it
  • de
  • en
  • fr

Top stories

News of the week

Perrigo looking for buyers of Prescription Pharmaceuticals division

Perrigo is reportedly about to put up for sale its division marketing prescription drugs, in order to better focus on OTCs and generics market, its core business. The division last year generated revenues of $969m, that is 20% of Perrigo’s…

Approvals

Procedures / New drug and device authorizations / Recommendations

Historical FDA approval to treatment “silencing” genes causing specific diseases

Yesterday was a historical day for medicine:  indeed, the FDA approved Alnylam Pharmaceuticals’ Onpattro (patisiran), a revolutionary treatment made up of a lipid complex that targets RNA selecting the genes responsible for polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis–a rare, highly…

Companies

Healthcare market news

Bayer loses first case over Monsanto’s glyphosate, investors abandon it (-10%)

Very hard momentum for Germany-based Bayer: A Californian judge some days ago ordered the company to pay a $289m refund for the damage caused by an herbicide containing glyphosate, marketed by the recently acquired Monsanto. The huge refunding could be…

Chemistry

Market and Technology

BASF to invest €10bn in China

German chemical company BASF announced that it is going to build a new integrated (verbund) chemical plant in China. This plant, which costs around €10bn, is expected to be put into operation by 2026. The venue is yet to be…

M&A

Mergers & Acquisitions

Perrigo looking for buyers of Prescription Pharmaceuticals division

Perrigo is reportedly about to put up for sale its division marketing prescription drugs, in order to better focus on OTCs and generics market, its core business. The division last year generated revenues of $969m, that is 20% of Perrigo’s…

Nutraceuticals

Food supplements

Mybiotics licenses to Ferring technology using bacterial flora to treat female diseases

Israel-based Mybiotics Pharma has signed an agreement with Ferring Holding to license the use of its MyCrobe technology, aimed at developing bacteria that benefit women’s health. MyCrobe has developed bacterial fermentation techniques based on the study of interactions between intestinal…

Pathology

Latest developments

Biotech BeiGene ready for listing in Hong Kong

China-based biotech BeiGene, listed in the US Nasdaq, has announced it pursues a listing in the Hong Kong stock market too. According to BeiGene’s management, this second listing should fetch the company at least $903m. The biotech will offer 65…

Safety

News on Product Safety

FDA issues warning about Intercept’s Ocaliva after 19 patients died

The FDA has officially warned doctors about the risks from Intercept Pharmaceuticals’ Ocaliva (obeticholic acid), after 19 patients on Intercept’s drug, developed to treat PBC (Primary Biliary Cholangitis) had died. The FDA, anyway, has specified that the deaths have occurred…

Trials

Preclinical Trials / Clinical Trials / Epidemiology

Japan ranks first for life expectancy; UK, US, Germany, Spain lose ground

The UK Office for National Statistics has published an interesting study analyzing the evolution of life expectancy in the country over the last few years, comparing it with global data. A life expectancy reduction has been observed in many industrialized…